Albert G. Fosmoe
Plus aucun poste en cours
Profil
Mr. Albert G.
Fosmoe, II, is Senior VP-Operations & Product Development at Oragenics, Inc.
Mr. Fosmoe was previously employed as Chief Regulatory Officer by OxThera AB, a Principal by IXION Technologies, Inc., and a Principal by U.S.
Biomaterials Corp.
He received his undergraduate degree from the University of Florida.
Anciens postes connus de Albert G. Fosmoe
| Sociétés | Poste | Fin |
|---|---|---|
AuxThera LLC
 AuxThera LLC Food: Specialty/CandyConsumer Non-Durables AuxThera LLC produces and commercializes food supplement for dogs to support weight loss. The company was founded by Albert G. Fosmoe II in 2014 and is headquartered in Gainesville, FL. | Directeur Général | - |
| ORAGENICS, INC. | Corporate Officer/Principal | - |
IXION Technologies, Inc.
 IXION Technologies, Inc. SemiconductorsElectronic Technology Ixion Technologies, Inc. manufactures components used in optical telecommunications, satellite, and the aerospace industry. The company was founded in 1999 and is headquartered in New Bedford, MA. | Corporate Officer/Principal | - |
U.S. Biomaterials Corp.
 U.S. Biomaterials Corp. Electronic Equipment/InstrumentsElectronic Technology U.S. Biomaterials Corp. developed tissue structure and function restoring materials and devices. The company was founded in 1991 and was headquartered in Jacksonville, FL. | Corporate Officer/Principal | - |
OxThera AB
 OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Directeur des opérations | 20/04/2010 |
Formation de Albert G. Fosmoe
| University of Florida | Undergraduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ORAGENICS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
OxThera AB
OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Health Technology |
IXION Technologies, Inc.
IXION Technologies, Inc. SemiconductorsElectronic Technology Ixion Technologies, Inc. manufactures components used in optical telecommunications, satellite, and the aerospace industry. The company was founded in 1999 and is headquartered in New Bedford, MA. | Electronic Technology |
U.S. Biomaterials Corp.
U.S. Biomaterials Corp. Electronic Equipment/InstrumentsElectronic Technology U.S. Biomaterials Corp. developed tissue structure and function restoring materials and devices. The company was founded in 1991 and was headquartered in Jacksonville, FL. | Electronic Technology |
AuxThera LLC
AuxThera LLC Food: Specialty/CandyConsumer Non-Durables AuxThera LLC produces and commercializes food supplement for dogs to support weight loss. The company was founded by Albert G. Fosmoe II in 2014 and is headquartered in Gainesville, FL. | Consumer Non-Durables |